|
|
Noveris Health Sciences Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization161.01 mln
Earnings Date08/17/2026
Key Fundamentals
EPS2.51
P/E0.78
ROIC-7.30
ROA9,902
EBITDA, mln3.26
EV / EBITDA40.98
EV / EBIT40.98
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-30.07% |
5
/ 100
 |
| 1 Month |
14.94% |
87
/ 100
 |
|
| |
